Updating!
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by XORTX Therapeutics Inc.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
NT 20-F | Document | Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F Acc-no: 0001104659-24-055242 (34 Act) Size: 24 KB |
May-01-2024 | 24899997 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001171843-24-002359 (34 Act) Size: 11 KB |
Apr-30-2024 | 24896534 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001171843-24-002113 (34 Act) Size: 16 KB |
Apr-22-2024 | 24859492 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001171843-24-001894 (34 Act) Size: 11 KB |
Apr-08-2024 | 24828178 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001171843-24-001893 (34 Act) Size: 9 KB |
Apr-08-2024 | 24828148 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001171843-24-001821 (34 Act) Size: 1574 KB |
Apr-04-2024 | 24820582 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001171843-24-001635 (34 Act) Size: 12 KB |
Mar-27-2024 | 24785804 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001171843-24-001463 (34 Act) Size: 15 KB |
Mar-20-2024 | 24765715 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001172661-24-001297 (34 Act) Size: 88 KB |
Feb-14-2024 | 24636531 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001171843-24-000025 (34 Act) Size: 15 KB |
Jan-03-2024 | 24504341 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001171843-24-000010 (34 Act) Size: 11 KB |
Jan-02-2024 | 24500342 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001104659-23-122414 (34 Act) Size: 356 KB |
Nov-30-2023 | 231455696 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001171843-23-007352 (34 Act) Size: 12 KB |
Nov-30-2023 | 231453969 |
424B5 | Document | Prospectus filed pursuant to Rule 424(b)(5) Acc-no: 0001104659-23-122148 (33 Act) Size: 610 KB |
Nov-30-2023 | 231453837 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001171843-23-007336 (34 Act) Size: 10 KB |
Nov-29-2023 | 231448417 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001171843-23-007137 (34 Act) Size: 758 KB |
Nov-16-2023 | 231412263 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001171843-23-006999 (34 Act) Size: 11 KB |
Nov-13-2023 | 231394995 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001171843-23-006873 (34 Act) Size: 11 KB |
Nov-08-2023 | 231389034 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001171843-23-006625 (34 Act) Size: 15 KB |
Nov-02-2023 | 231369975 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001171843-23-006509 (34 Act) Size: 10 KB |
Oct-30-2023 | 231356696 |
Recent 20 filings. View all XORTX Therapeutics Inc. filings
Huge help thank you for your help .. y'all make it so much easier
young lad who new his job ansered questions and new what was best for me.
It's being easier working on the website. And I recommend, it's a great website
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by